United States:
FDA Reopens Docket To Collect Information On Innovative Means To Address The Misuse And Abuse Of Opioid Analgesics
To print this article, all you need is to be registered or login on Mondaq.com.
In the July 8, 2014, Federal Register, FDA reopened the docket to
receive suggestions, recommendations, and comments on innovative
packaging, storage, and disposal systems, technologies, or designs
that could be used to prevent or deter misuse and abuse of opioid
analgesics by patients and others, originally noticed in the April
9, 2014, Federal Register. The initial comment period
had just closed on June 9, 2014. Comments are due
August 7, 2014.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
